Mineralys Therapeutics Inc.
MLYS | NASDAQ
$29.28
+$0.97 (+3.43%)
Sep 22, 2026, 1:04 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -241.07M | -39.34M | -32.23M | -36.93M | -43.27M | -42.21M | -48.95M | -56.34M | -41.01M | -31.51M | -24.39M | -22.76M | -12.14M | -12.61M | -9.07M | -6.68M | -6.48M | -7.57M | -7.08M |
Depreciation & Amortization | 120K | 6K | 13K | 15K | 16K | 15K | 15K | 11K | 9K | 8K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Stock-Based Compensation | 7.36M | 6.55M | 5.29M | 5.84M | 4.55M | 3.65M | 3.13M | 3.14M | 2.87K | 2.19M | 1.46M | 1.58M | 1.28M | 749K | 218K | 192K | 26K | 19K | 16K |
Other Working Capital | n/a | -2.35M | -6.56M | 4.59M | 10.81M | -4.34M | -19.81M | 5.7M | 10.65M | 12.68M | -3.98M | 4.11M | -7.37M | -61K | -921K | -532K | -49K | 108K | 2.18M |
Other Non-Cash Items | 198.98M | -4.63M | -4.21M | -2.4M | -2.23M | -1.05M | -1.34M | -2.71M | 22.13K | -2.51M | -2.07M | -1.96M | -1.98M | -855K | -410K | 30K | 1.03M | 864K | n/a |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 2.06M | -2.06M | -6.74M | 4.6M | 10.77M | -5.89M | -19.71M | 5.72M | 10.83M | 12.68M | -3.98M | 4.11M | -7.54M | -61K | -921K | -532K | -49K | 108K | 2.18M |
Operating Cash Flow | -32.56M | -39.47M | -37.89M | -28.87M | -30.17M | -45.49M | -66.84M | -50.19M | -30.15M | -19.14M | -28.98M | -19.03M | -20.39M | -12.78M | -10.19M | -6.99M | -5.47M | -6.58M | -4.89M |
Capital Expenditures | n/a | n/a | -15K | n/a | n/a | n/a | n/a | -37K | n/a | -59K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -310.22M | -347.44M | -268.47M | -300.51M | -117.88M | -127.88M | -63.93M | -58.86M | -127.26M | -123.39M | -73.09M | -55.99M | -56.14M | -162.75M | n/a | -71.76M | n/a | n/a | n/a |
Sales Maturities Of Investments | 325M | 302.5M | 165M | 150M | 75M | 35M | 147.5M | 138.5M | 135M | 67.5M | 65M | 60M | 40M | 22.5M | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -200M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 50M | n/a | n/a | n/a | n/a |
Investing Cash Flow | -185.22M | -44.94M | -103.49M | -150.51M | -42.88M | -92.88M | 83.57M | 79.61M | 7.74M | -55.95M | -8.09M | 4.01M | -16.14M | -140.25M | 50M | -71.76M | n/a | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | 292K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 243.26M | n/a | n/a | 6.6M | n/a | 113K | -47K | -41K | -92K | 86K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Financial Cash Flow | 243.26M | 24.27M | 96.7M | 295.19M | 9.83M | 189.28M | 90K | -1K | -152K | 116.21M | 74K | 184K | -581K | 203.57M | -1.07M | -561K | 117.65M | 12M | n/a |
Net Cash Flow | 25.49M | -60.14M | -44.68M | 115.81M | -63.22M | 50.92M | 16.82M | 29.42M | -22.56M | 41.11M | -37M | -14.84M | -37.11M | 50.55M | 38.75M | -79.31M | 112.18M | 5.42M | -4.89M |
Free Cash Flow | -32.56M | -39.47M | -37.9M | -28.87M | -30.17M | -45.49M | -66.84M | -50.22M | -30.15M | -19.2M | -28.98M | -19.03M | -20.39M | -12.78M | -10.19M | -6.99M | -5.47M | -6.58M | -4.89M |
Adj. Free Cash Flow | -39.91M | -46.02M | -43.19M | -34.71M | -34.72M | -49.13M | -69.98M | -53.36M | -30.15M | -21.39M | -30.44M | -20.61M | -21.66M | -13.52M | -10.4M | -7.18M | -5.5M | -6.6M | -4.91M |
Maintenance CapEx | n/a | n/a | -13K | n/a | n/a | n/a | n/a | -11K | n/a | -8K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Growth CapEx | n/a | n/a | -2K | n/a | n/a | n/a | n/a | -26K | n/a | -51K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Owner Earnings | -32.56M | -39.47M | -37.9M | -28.87M | -30.17M | -45.49M | -66.84M | -50.2M | -30.15M | -19.15M | -28.98M | -19.03M | -20.39M | -12.78M | -10.19M | -6.99M | -5.47M | -6.58M | -4.89M |
Add to Watchlist
Select watchlists to add or remove MLYS